Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

BACKGROUND: Although the addition of bevacizumab significantly improves the efficacy of chemotherapy for advanced breast cancer, regulatory concerns still exist with regard to the magnitude of the benefits and the overall safety profile. METHODS: A literature-based meta-analysis to quantify the magn...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuppone, Federica, Bria, Emilio, Vaccaro, Vanja, Puglisi, Fabio, Fabi, Alessandra, Sperduti, Isabella, Carlini, Paolo, Milella, Michele, Nisticò, Cecilia, Russillo, Michelangelo, Papaldo, Paola, Ferretti, Gianluigi, Aapro, Matti, Giannarelli, Diana, Cognetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120715/
https://www.ncbi.nlm.nih.gov/pubmed/21569417
http://dx.doi.org/10.1186/1756-9966-30-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120715/
https://www.ncbi.nlm.nih.gov/pubmed/21569417
http://dx.doi.org/10.1186/1756-9966-30-54

Ejemplares similares